Chinese Markets for Hypertension Drugs : Market Research Report

Chinese Markets for Hypertension Drugs

Published by: Asia Market Information & Development Company

Published: Apr. 1, 2009 - 188 Pages

I. INTRODUCTION: Report Scope and Methodology; Executive Summary
II. BUSINESS ENVIRONMENT: Economic Outlook; Key Economic Indicators; Industrial Output; Population and Labor; Foreign Investment; Foreign Trade; Financial and Tax Regulations; Banking System and Regulations; Foreign Exchange; Taxes, Tariff and Custom Duties
III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS: Hypertension Drugs Industry Structure; Market Size; Market Growth Drivers; Hypertension Drugs Sales Volume; Major Producer Facility Locations; Major Producers�f Sales Volume and Market Share; Labor Cost; Potential Entrants; Major Distributors; Major Foreign Investment; Technology Development
IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND: Market Overview by Drugs Classification; Calcium Channel Blocker; Felodipine; Nifedipine; Amlodipine; Nisoldipine; Nimodipine; Nitrendipine; Angiotensin ‡U Receptor Antagonists Drug; Losartan; Valsartan; Irbesartan; Telmisartan; Candesartan; Angiotensin-Converting Enzyme Inhibitor; Benazepril; Enalapril; Captopril; Lisinopril; Ramipril; Other Hypertension Drugs; Import and Export; Market Overview by Producers; Pricing Trend
V. HYPERTENSION DRUGS MARKET OUTLOOK: Hypertension Drugs Markets Outlook Overview; Government Regulation; Health Care Insurance Industry Overview; Consumer Spending Trends; Demographic Trends; Health Care Industry Trends; Hospitals and Hospital Beds; Physicians and Physician Visits
VI. MARKETING STRATEGIES: China Market Entry Overview; China�fs Distribution System; Hypertension Drugs Distribution Channels; Transportation and Freight Infrastructure; Communications; China�fs Market Entry; Export to China; Indirect export; Direct Export; License and Contract Manufacture; Assembling in China; Contract Manufacturing; Trade Permit; Investment; Equity Joint Venture; Contractual Joint Venture; Wholly Foreign-Owned Enterprise
VII. HYPERTENSION DRUGS PRODUCER DIRECTORY: Profiles of Hypertension Drugs Producers and Major Consumption in Industry
LIST OF TABLES
I. INTRODUCTION: Economic Outlook Summary
II. BUSINESS ENVIRONMENT: Key Economic Indicators; Industrial Output; Population and Labor Force Trends; Foreign Investment and Loans; Foreign Trade
III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS: Calcium Channel Blocker Sales Volume and Market Share by Drugs Classification in 2008; Angiotensin ‡U Receptor Antagonists Drug Sales Volume and Market Share by Drugs Classification in 2008; Angiotensin-Converting Enzyme Inhibitor Sales Volume and Market Share by Drugs Classification in 2008; Other Hypertension Drugs Sales Volume and Market Share by Drugs Classification in 2008; Hypertension Drugs Sales Volume; Major Producer Facility Location; Major Hypertension Drugs Producer Sales Volume; Major Foreign Investment in China
IV.HYPERTENSION DRUGS PRODUCTION AND DEMAND: Hypertension Drugs Sales Volume by Drugs Classification; Calcium Channel Blocker Sales Volume and Market Share by Drugs Classification in 2008; Angiotensin ‡U Receptor Antagonists Drug Sales Volume and Market Share by Drugs Classification in 2008; Angiotensin-Converting Enzyme Inhibitor Sales Volume and Market Share by Drugs Classification in 2008; Other Hypertension Drugs Sales Volume and Market Share by Drugs Classification in 2008; Hypertension Drugs Import by Drugs Classification; Hypertension Drugs Export by Drugs Classification; Hypertension Drugs Major Producer, Sales Volume, and Market Share in 2008
V.HYPERTENSION DRUGS MARKET OUTLOOK: Consumer Spending Trends; Demographic Trends; Health Care Industry Trends; Hospitals and Hospital Beds; Physicians and Physician Visits
VI.MARKETING STRATEGIES
VII. HYPERTENSION DRUGS PRODUCER DIRECTORY
LIST OF CHARTS
I. INTRODUCTION: Hypertension Drugs Sales Volume
II. BUSINESS ENVIRONMENT: China�fs GDP and Growth Rate; Industrial Output by Ownership; China�fs Imports and Exports
III. HYPERTENSION DRUGS INDUSTRY ASSESSMENTS: Total Hypertension Drugs Sales Volume; Hypertension Drugs Sales Volume by Drugs Classification in 2008; Calcium Channel Blocker Market Share by Drugs Classification in 2008; Angiotensin-Converting Enzyme Inhibitor Market Share by Drugs Classification in 2008; Angiotensin ‡U Receptor Antagonists Drug Market Share by Drugs Classification in 2008; Other Hypertension Drugs Market Share by Drugs Classification in 2008; Hypertension Drugs Sales Volume
IV. HYPERTENSION DRUGS PRODUCTION AND DEMAND: Hypertension Drugs Sales Volume; Hypertension Drugs Import; Hypertension Drugs Export; Hypertension Drugs Sales Volume by Drugs Classification in 2008; Calcium Channel Blocker Sales Volume and Market Share; Calcium Channel Blocker Market Share by Drugs Classification in 2008; Angiotensin ‡U Receptor Antagonists Drug Sales Volume and Market Share; Angiotensin ‡U Receptor Antagonists Drug Market Share by Drugs Classification in 2008; Angiotensin-Converting Enzyme Inhibitor Sales Volume and Market Share; Angiotensin-Converting Enzyme Inhibitor Market Share by Drugs Classification in 2008

Abstract

China's demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Chinese Markets for Hypertension Drugs

Table of Contents

Abstract